Ontology highlight
ABSTRACT:
SUBMITTER: Bergeron RJ
PROVIDER: S-EPMC2951135 | biostudies-literature | 2010 Apr
REPOSITORIES: biostudies-literature
Bergeron Raymond J RJ Bharti Neelam N Wiegand Jan J McManis James S JS Singh Shailendra S Abboud Khalil A KA
Journal of medicinal chemistry 20100401 7
(S)-2-(2,4-Dihydroxyphenyl)-4,5-dihydro-4-methyl-4-thiazolecarboxylic acid (2) was abandoned in clinical trials as an iron chelator for the treatment of iron overload disease because of its nephrotoxicity. However, subsequent investigations revealed that replacing the 4'-(HO) of 2 with a 3,6,9-trioxadecyloxy group, ligand 4, increased iron clearing efficiency (ICE) and ameliorated the renal toxicity of 2. This compelled a closer look at additional polyether analogues, the subject of this work. T ...[more]